SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-016551
Filing Date
2018-11-27
Accepted
2018-11-27 08:01:29
Documents
5
Period of Report
2018-11-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k112718_therapixbioscience.htm 6-K 28460
2 SECURITIES PURCHASE AGREEMENT DATED NOVEMBER 23, 2018 f6k112718ex10-1_therapixbio.htm EX-10.1 152665
3 REGISTRATION RIGHTS AGREEMENT DATED NOVEMBER 23, 2018 f6k112718ex10-2_therapixbio.htm EX-10.2 92104
4 DEBENTURE DATED NOVEMBER 23, 2018 f6k112718ex10-3_therapixbio.htm EX-10.3 120773
5 PRESS RELEASE DATED NOVEMBER 27, 2018 f6k112718ex99-1_therapixbio.htm EX-99.1 10381
  Complete submission text file 0001213900-18-016551.txt   405449
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 181201986
SIC: 2834 Pharmaceutical Preparations